InvestorsHub Logo

rayank

11/07/14 6:41 AM

#532 RE: maytepper #531

SNTA: "I liked this stock at $5.00, and find it offers a very compelling risk-reward profile at $2.80. I remain bullish".
http://seekingalpha.com/article/2655065-update-synta-pharmaceuticals-reports-q3-earnings-where-i-went-wrong?uprof=51